Founded 1884, the Ohio Northern University's College of Pharmacy has had the privilege to graduate over 7,000 pharmacists over 120 years. The R. H. Raabe College of Pharmacy is distinctive among other colleges of pharmacy as it integrates a comprehensive foundation in the pharmaceutical sciences and the practice of pharmacy along with a strong liberal arts curriculum. Our graduates are particularly active in local, state, and national health-related organizations.
The College is committed to assuring that all students receive the finest education possible and is now offering continuing education to pharmacy professionals through distance learning methods. Our faculty members are dedicated scholars with a desire to assist student learning. We welcome your inquiries regarding the profession and our academic program.
The Business of Health Care: Wholesalers of Prescription Drugs
November 2008 Law & Mortar Newsletter - If you've submitted a hardcopy
quiz, credit can only be issued once.
048-000-08-045-H03-P
Law & Mortar - The Business of Health Care: Wholesalers of Prescription Drugs
This CE is approved for Ohio juris prudence.
ACPE number: 048-000-08-045-H03-P
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
The Business of Health Care: The Pharmaceutical Industry
August 2008 Law & Mortar Newsletter - If you've submitted a hardcopy
quiz, credit can only be issued once.
048-000-08-035-H03-P
Law & Mortar - The Business of Health Care: The Pharmaceutical Industry
This CE is approved for Ohio juris prudence.
ACPE number: 048-000-08-035-H03-P
Franklin Z. Wickham, D.Pharm., M.S., R.Ph., previous Director of the Pharmacy Law Institute and previous executive director of the Ohio State Board of Pharmacy
Objectives:
At the completion of this program, the participant will be able to:
- Explain the application of general business principles to the health care industry.
- Identify federal and state government agencies impacting development, manufacture and legal distribution of pharmaceuticals.
- Describe the background of patent law and list specific examples that apply to pharmaceutical manufacturers maintaining economic advantage.
- Outline the adoption and repeal of state anti-substitution laws.
-. List effective prescription drug marketing strategies.
Brief Review of Chronic Heart Failure
Fall 2008 Ampule - If you've submitted a hardcopy quiz, credit can only issued once.
048-000-08-042-H103-P
Danielle Fennema, PharmD, Pharmacy Practice Resident at Physicians Inc/Ohio Northern University
With: Michael Rush, PharmD, Preceptor at Physicians Inc and Kelly Shields, PharmD, Director of Drug Information Services at Ohio Northern University
This article is designed to provide a brief review of heart failure and its major components that include pathophysiology, causes, diagnosis and testing, heart failure classifications, and treatments. The treatment options are divided into non-pharmacologic versus pharmacologic.
Objectives:
At the completion of this program, the participant will be able to:
- Recognize signs and symptoms of left and right ventricular heart failure.
- Identify causes of heart failure.
- List the ACC/AHA heart failure stages.
- Recognize the clinical trials supporting the ACC/AHA heart failure guidelines.
- The material presented was unbiased.
Ohio
Administrative Code: Physician Assistants and Pharmacy Practice
February 2008 Law & Mortar Newsletter - If you've submitted a hardcopy
quiz, credit can only be issued once.
048-000-08-016-H03-P
This CE is approved for Ohio juris prudence.
Dr. Wickham, previous Director of Pharmacy Law
Institute, discusses the new rules adopted by the State Medical Board
regarding the prescribing of drugs by physician assistants (PAs). This
CE is approved by the Ohio State Board of Pharmacy for Juris Prudence.
Objectives:
-Explain the legislation outlining the physician assistant (PA) scope
of practice and prescriptive authority, and the purpose of the Quick Summary
of Physician Asssistant Prescriptive Authority.
-Describe the format of the proposed physician assistant (PA) Formulary
and current rule status.
-State the types of PA supervision and requirements, and prescriptive
restrictions of the supervisory plan.
-List information available on PAs on the State Medical Board website
through the Ohio e-License Center.
-Specify how pharmacists verify the PA's prescriptive
authority and validity of PA-generated prescriptions.
Overview
of Migraines
048-000-07-030-H01-P
Dr. Martin, Assistant Professor of Pharmacy Practice,
discusses the definition, prevention, pharmacologic therapy, and non-pharmacologic
therapy for migraine headaches.
Objectives:
-Describe current trends in the use of pharmacotherapy for migraine prevention.
-Explain the indications for, goals of, and potential benefits of the
use of pharmacotherapy for migraine prevention.
-Explain factors to consider in the use and selection of pharmacotherapy
for migraine prevention.
-Identify pros and cons of the currently available pharmacologic options
for migraine prevention.
-Describe how to assess efficacy and tolerability of medications used
in migraine prevention.
-Educate patients on the use of both acute and preventive migraine pharmacotherapy.
Pneumonia
Treatment
048-000-07-027-H01-P
Dr. Roecker, Associate Professor of Pharmacy Practice,
discusses the epidemiology, at risk populations, pathogenesis, and treatment
of community acquired pneumonia.
Objectives:
At the completion of this program, the participant will be able to:
-Describe the differences between community acquired pneumonia and nosocomial
pneumonia.
-List the presenting symptoms and diagnostic tests used in the workup
of pneumonia.
-List the treatment options for community acquired pneumonia based on
patient specific risk factors.
-List the treatment options for nosocomial pneumonia based on patient
specific risk factors.
-Describe appropriate pneumonia prevention techniques.
Principles
and Concepts Regarding Dietary Supplements
048-000-07-024-H04-P
Dr. Shields, Assistant Professor of Pharmacy Practice,
Director of The Drug Information Center, discusses the use,
epidemiology, product regulation, purity, standardization, information
resources, and the pharmacist role regarding dietary supplements.
Objectives:
-Describe the prevalence and factors impacting patient use of dietary
supplements.
-Identify issues of product quality related to dietary supplements.
-Identify current programs assessing product quality.
-Describe the role of the pharmacist in providing care to patients using
supplements.
-Describe patient communication techniques for patients using supplements.
Review
of Enzymology for Pharmacists
048-000-07-029-H01-P
Dr. Stockert, Assistant Professor of Biochemistry,
reviews enzyme catalysis, transition state theory, and enzyme kinetics.
Objectives:
-Review the basics of enzyme catalysis including transition state theory.
-List four major methods utilized by enzymes for stabilization of the
transition state: 1) proximity effects 2) acid-base catalysis 3) covalent
catalysis 4) strain.
-Differentiate between steady state and pre-steady state kinetics.
-Differentiate between zero-order and first-order kinetics on the Michaelis-Menton
graph.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the
Vmax and Km.
-List three classes of inhibitors: 1) competitive 2) non-competitive and
3) un-competitive.
-Given a Michaelis-Menton graph or Lineweaver-Burke plot, identify the
type of inhibition.
-List the necessity of pre-steady state kinetics for design of mechanism
based inhibitors.
Topics
in Law for Ohio Pharmacists
048-000-07-049-H03-P
This CE is approved for Ohio juris prudence.
Dr. Sullivan, associate professor and chair of pharmacy
practice, has provided continuing education regarding Ohio law for many
years. In this article, he discusses the requirement for drugs compounded
by pharmacies for direct administration by a prescriber, the requirements
of charitable pharmacies in Ohio, requirements for dispensing buprenorphine,
and requirements for pharmacy interns.
Objectives:
- Discuss the requirements for drugs compounded by pharmacies for direct
administration by a prescriber.
- Discuss the requirements of charitable pharmacies in Ohio.
- List the requirements of pharmacists when dispensing buprenorphine.
- Discuss the requirements for pharmacy interns in Ohio.
Retail health Clinic and Vision Center Practitioners
May 2008 Law & Mortar Newsletter - If you've submitted a hardcopy
quiz, credit can only be issued once.
048-000-08-029-H03-P
This CE is approved for Ohio juris prudence.
"Recent news reports document a change in
health care delivery in this county in that
corporations owning and operating retail
pharmacies throughout the United States
are opening 'retail clinics' in their stores. Dr. Wickham is the previous Director of Pharmacy Law
Institute.
Objectives:
- State background information on retail
health clinics from patient, employer, and
insurer standpoints.
- List the major companies in Ohio with retail
health clinics and compare their work models
and staffing.
- Explain Ohio law concerning credentialing,
certification, and scope of practice of nurse
practitioners.
- Describe CVS Caremark's MinuteClinic
model.
- Explain the scope of practice of optometrists
practicing in vision care centers in retail health
clinics, including H.B. 149 scope update.
The Role of a Pharmacist in Managing Amiodarone Therapy
Spring 2008 Ampule - If you've submitted a hardcopy
quiz, credit can only be issued once.
048-000-08-017-H01-P
Mary Ann Tucker developed this CE as part of her ambulatory care residency at Blanchard Valley Medical Associates under the direction of Teresa Hoffman, a shared faculty member at Ohio Northern, and Kelly Shields, director of Drug Information at Ohio Northern.
Objectives:
- Understand the various labeled and unlabeled uses of amiodarone.
- Understand the unique mechanism of action and pharmacokinetics of amiodarone and how these factors impact adverse reactions.
- Identify the most common adverse drug reactions associated with amiodarone.
- Identify necessary monitoring for a patient on long-term amiodarone therapy.
There is a $10.00 fee required prior to accessing each Continuing Education
Program. You will be redirected to a secure site to enter your credit
card information. Your online statement of credit will be available for
printing after successful completion of the quiz. If you have any problems,
please contact Lynn Bedford at 419-772-1871.
